Healthcare Due Diligence and Dealbreakers

What might cause a private equity GP to back away from a healthcare investment? Deal-breakers include problems in manufacturing, management, quality of earnings, clinical compliance, referral sources, reimbursement. The healthcare space is so perilous that due diligence has become more important than ever to understand risk.

The last in a four-part Privcap thought-leadership series features James Elrod of Vestar Capital Partners, Sherrill Neff of Quaker Partners, and Tammy Hill of RSM and includes an expert Q&A with Hill of RSM, sponsor of this series.